Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ISG15 anticorps (N-Term)

ISG15 Reactivité: Humain WB, IHC (p) Hôte: Lapin Polyclonal RB02791 unconjugated
N° du produit ABIN387983
  • Antigène Voir toutes ISG15 Anticorps
    ISG15 (ISG15 Ubiquitin-Like Modifier (ISG15))
    Épitope
    • 9
    • 7
    • 7
    • 5
    • 4
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 31-61, N-Term
    Reactivité
    • 60
    • 15
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    Humain
    Hôte
    • 55
    • 6
    • 1
    Lapin
    Clonalité
    • 55
    • 7
    Polyclonal
    Conjugué
    • 36
    • 5
    • 5
    • 4
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp ISG15 est non-conjugé
    Application
    • 48
    • 34
    • 30
    • 8
    • 7
    • 3
    • 3
    • 3
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Purification
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogène
    This ISG15 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 31-61 amino acids from the N-terminal region of human ISG15.
    Clone
    RB02791
    Isotype
    Ig Fraction
    Top Product
    Discover our top product ISG15 Anticorps primaire
  • Indications d'application
    WB: 1:1000. WB: 1:1000. WB: 1:1000. IHC-P: 1:50~100
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-20 °C
    Stockage commentaire
    Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
    Date de péremption
    6 months
  • Cheriyamundath, Basu, Haase, Doernberg, Gavert, Brabletz, Ben-Zeev: "ISG15 induction is required during L1-mediated colon cancer progression and metastasis." dans: Oncotarget, Vol. 10, Issue 67, pp. 7122-7131, (2019) (PubMed).

    Speer, Li, Buta, Payelle-Brogard, Qian, Vigant, Rubino, Gardner, Wedeking, Hermann, Duehr, Sanal, Tezcan, Mansouri, Tabarsi, Mansouri, Francois-Newton, Daussy, Rodriguez, Lenschow, Freiberg et al.: "ISG15 deficiency and increased viral resistance in humans but not mice. ..." dans: Nature communications, Vol. 7, pp. 11496, (2018) (PubMed).

    Katzenell, Leib: "Herpes simplex virus and interferon signaling induce novel autophagic clusters in sensory neurons." dans: Journal of virology, (2016) (PubMed).

    Huang, Bulavin: "Oncogene-mediated regulation of p53 ISGylation and functions." dans: Oncotarget, Vol. 5, Issue 14, pp. 5808-18, (2015) (PubMed).

    Schanz, Baston-Büst, Heiss, Beyer, Krüssel, Hess: "Interferon stimulated gene 15 expression at the human embryo-maternal interface." dans: Archives of gynecology and obstetrics, Vol. 290, Issue 4, pp. 783-9, (2014) (PubMed).

  • Antigène
    ISG15 (ISG15 Ubiquitin-Like Modifier (ISG15))
    Autre désignation
    ISG15 (ISG15 Produits)
    Synonymes
    anticorps G1P2, anticorps IFI15, anticorps IP17, anticorps UCRP, anticorps hUCRP, anticorps ISG15, anticorps g1p2, anticorps si:rp71-1c23.2, anticorps G1p2, anticorps IGI15, anticorps Irfp, anticorps ISG17, anticorps ISG17/UCRP, anticorps ISG15 ubiquitin-like modifier, anticorps ISG15, anticorps isg15, anticorps Isg15
    Sujet
    ISG15 is secreted from monocytes in response to type I interferons and causes natural killer (NK)-cell proliferation and an augmentation of non-MCH (major histocompatibility complex)-restricted cytotoxicity. Synthesis is stimulated by IFN-alpha or IFN-beta or IFN-omega , but not IFN-gamma . ISG15 expression is also induced by overexpression of interferon regulatory factors that participate in transcriptional regulation of IFN genes, and by influenza B virus. ISG15 is secreted also by cell lines of monocyte, T-lymphocyte, B-lymphocyte, human fibroblasts, and epithelial origins. The induction of terminal differentiation in human melanoma cells is associated with alterations in ISG15 expression. Enhancement of NK cell proliferation, augmentation of non-major histocompatibility complex-restricted cytotoxicity, and induction of IFN-gamma from T cells identify ISG15 as a member of the cytokine cascade and suggest that it may be responsible for amplifying and directing some of the immunomodulatory effects of IFN-alpha or IFN-beta. ISG15 has has also been shown to function intracellularly as a ubiquitin homolog.
    Poids moléculaire
    17888
    ID gène
    9636
    NCBI Accession
    NP_005092
    UniProt
    P05161
Vous êtes ici:
Support technique